Nosocomial sepsis is a serious problem for neonates who are admitted for intensive care. As it is associated with increases in mortality, morbidity, and prolonged length of hospital stay, both the human and fiscal costs of these infections are high. Although the rate of nosocomial sepsis increases with the degree of both prematurity and low birth weight, no specific lab test has been shown to be very useful in improving our ability to predict who has a ''real'' blood-stream infection and, therefore, who needs to be treated with a full course of antibiotics. As a result, antibiotic use is double the rate of ''proven'' sepsis and we are facilitating the growth of resistant organisms in the neonatal intensive care unit. The purpose of this article is to review the topic of nosocomial infections in neonates.
INTRODUCTION Definition
The US Department of Health and Human Services Centers for Disease Control and Prevention defines nosocomial infection as an infection during hospitalization that was not present or incubating at the time of admission. 1 Most authors describing neonatal infection find it convenient to use the terms ''early-onset'' and ''late-onset'' infection. Early-onset infections are confirmed infections in the first three days of life, whereas late-onset infections occur after the third day. Nosocomial infection is equivalent to late-onset, or infection after the first 72 hours of life. 2 Infection rates may be stated as percent of admissions, percent of liveborns, or by number of infections per 1000 patient days. As 20 to 30% of preterm neonates may have two or more nosocomial infection episodes, infection rates per patient day probably gives a more accurate idea of magnitude, whereas rates per patient group (admissions, liveborns, birth-weight range, gestational age range) give a good idea of attack or incidence rates.
It is also important to distinguish nosocomial infection, which usually means any infection (blood stream, pneumonia, central nervous system, or urinary tract), from nosocomial sepsis, which usually relates primarily to blood-stream infection. Another challenge is the definition of what constitutes infection. Most reports define confirmed nosocomial infection as a positive blood, spinal fluid, or urine culture. A few reports make the distinction between a positive culture with clinical signs of infection, a positive culture with no signs of infection, or signs of infection with a negative culture.
While pneumonia, urinary tract infections, meningitis, and sepsis are all important causes of nosocomial infection, sepsis is the most commonly reported. Additionally, sepsis frequently accompanies pneumonia, urinary tract infections, and meningitis. Therefore, the goal of this paper is to review the topic of nosocomial sepsis (clinical presentation, diagnosis, and predisposing factors).
Incidence
The neonatal intensive care unit (NICU) nosocomial infection rate has increased over the past decade. 2, 3 The total number of neonates who develop nosocomial infection per admission varies from 6.2 4 to 33% 5 or, when reported as total infections per 1000 patient days, the rate varies from 4.8 4 to 22. 6 Blood-stream infections (nosocomial sepsis) vary from 3 to 28% of admissions. 4, 5, [7] [8] [9] The variability in infection rates depends on the gestational age, distribution of the infants surveyed for the report, and on the specific environment and care practices. 10 Even when statistical correction has been made for case mix, the variability between centers generally remains. 5, 11 While ''confirmed'' nosocomial infection occurs in approximately 30% of very-low-birth-weight neonates, antibiotic use (especially vancomycin) is much more common (see Figure 1 ). This suggests that suspected nosocomial infection is a much more frequent occurrence than ''confirmed'' nosocomial infection. Suspected nosocomial infection often drives the use of broadspectrum antibiotics, which may predispose patients to more serious infections like candidemia and Gram-negative sepsis. The real problem is that we have a very limited gold standard in diagnosing true sepsis; no lab test identifies all the patients that need to be treated and some degree of ''overtreatment'' is unavoidable, even if risky, in terms of subsequent infections.
CLINICAL PRESENTATION, ORGANISMS, AND OUTCOMES
The presentations and outcomes of neonates with specific organisms as the cause for their sepsis are unique to the organism.
Presentation
The dominant presenting features of septicemia or sepsis include: increasing apnea (55%); feeding intolerance, abdominal distension, or guaiac-positive stools (43%); need for increased respiratory support (29%); and lethargy and hypotonia (23%). 12 An abnormal white blood-cell count (46%), unexplained metabolic acidosis (11%) or hyperglycemia (10%) are the most common laboratory indicators. 12 Gram-negative nosocomial sepsis often presents with a more rapid clinical deterioration and is commonly associated with shock and coagulation problems. 13 In addition, the pathogens associated with fulminant (lethal within 48 hours) lateonset sepsis are most often Gram-negative organisms. The frequency of fulminant sepsis is the highest for Pseudomonas sp, 20 of 36 (56%; 95% CI: 38 to 72%), and lowest for coagulasenegative Staphylococci, four of 277 (1%; 95% CI: 0 to 4%). 13 A set of clinical signs (apnea, bradycardia, etc.) and laboratory values (leukocytosis, immature white blood cells, neutropenia, and elevated c-reactive protein or interleukins) suggest the diagnosis of sepsis, but they have poor positive predictive value. 12 Despite these limitations, the combination of clinical signs and laboratory findings has been used to define ''clinical sepsis'' and is often used to decide whom to treat and when to stop treatment. The uncertainty generated by the absence of good predictors for nosocomial sepsis is one of the causes for the overuse of antibiotics.
14 Organisms Gram-positive and Gram-negative bacteria account for 55.4 and 31.2% of microbes, respectively. 15 The most common organisms are Staphylococci, Escherichia coli and Klebsiella, and Candida ( Figure 2) . 1, 15 In addition to the pathogens that are easily grown in blood-culture media, other organisms that are fastidious organisms (e.g., Mycoplasma and Ureaplasma species) may be missed.
Outcomes
Mortality after Gram-negative sepsis (26.2%) and Candida sepsis (27.6%) is similar and significantly higher than with Grampositive sepsis (8.7%). 15 However, the virulence of organisms like coagulase-negative Staphylococci may be underestimated because many cultures that grow Gram-positive bacteria represent skin contaminants rather than true blood-stream infections.
Fungal sepsis is more indolent than Gram-negative sepsis and more fulminant than coagulase-negative Staphylococci. It is commonly associated with thrombocytopenia and occurs more often in neonates with a birth weight <0.750 kg and those who are very premature (estimated gestational age <26 weeks). 16 Acquired nosocomial Candida sepsis is associated with significant morbidity. 17 Data on 27 Candida-infected survivors showed that all of them developed chronic lung disease compared with 33% in the control cases (p<0.01). The survivors also had a higher incidence of periventricular leukomalacia (26 vs 12%, p ¼ 0.06); an increase in severe retinopathy of prematurity (22 vs 9%, p ¼ 0.04); and adverse neurological outcomes (60 vs 35%) compared to neonates in the control group. 17 
DIAGNOSIS OF NOSOCOMIAL SEPSIS
The gold standard for the diagnosis of nosocomial sepsis remains the finding of a positive blood culture for a known pathogen. There are two common errors that are made in evaluating neonates with possible sepsis. The reduction of both types of these errors is important.
Type I Errors (False Positive, Contaminant) A type I error (false positive, contaminant) is accepting a positive culture as real when the patient is not truly bacteremic. Type I errors lead to the overuse of antibiotics and can subsequently increase the risks for more serious infections.
The best way to avoid type I errors is to prevent coagulasenegative Staphylococci contamination of blood cultures. Prepping the skin prior to puncture requires broad-spectrum site antisepsis; however, the skin of the neonate, especially the preterm neonate, is more susceptible to damage from antiseptic agents. Additionally, the thinner layers of epidermis in premature neonates also contribute to the enhanced absorption of disinfectants. [18] [19] [20] Four agents have been shown to be effective at disinfecting the skin: povidone-iodine, tincture of iodine, 70% isopropyl alcohol, and chlorhexidine gluconate. [21] [22] [23] Of these, chlorhexidine gluconate and povidone-iodine appear to be the best agents after taking into account the risks of systemic absorption and local skin irritation. A 30-second exposure time is recommended, followed by removal with sterile water or saline. [24] [25] [26] It is equally important to avoid contamination of the culture from a deep-line hub. Use of microbiologic techniques to differentiate a contaminated specimen from a real specimen includes colony counts and time to detection, both of which can help differentiate true sepsis from line contamination. [27] [28] [29] It is also possible to reduce the risk of a type I error by limiting the number of personnel who draw cultures, needle sticks, and times that the deep-line hub is entered.
Type II Errors (False Negative, Inadequate Culture) Type II errors (false negative, inadequate culture) occur when a negative blood culture result is accepted as proof that the patient is not infected when, in fact, the patient has true bacteremia that has not been detected by the blood culture. Consequently, type II errors can lead to undertreatment of neonates with life-threatening sepsis.
The best way to reduce type II errors is to obtain adequate blood culture specimens. Two variables determine the volume of blood necessary for an adequate sample: the sensitivity of the detection system and the probability of finding at least one microorganism in the blood culture bottle (density of bacteremia or fungemia in the blood sample). 30 Obtaining small volumes of blood in the face of low-density bacteremia or fungemia runs an appreciable risk of not finding an organism in the culture bottle. 30, 31 In neonatal and pediatric case control studies, as many as 60% of culture results will be falsely negative if only 0.5 ml of blood is obtained in lowcolony-count sepsis. 30, 32, 33 Obtaining 1 ml of blood for culture improves culture yields in neonates, but this can represent a significant blood-volume loss for very-low-birth-weight neonates.
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The use of ancillary tests (C-reactive protein, 34, 35 white blood count, 36 interleukin-6, 37,38 etc.) may increase the odds of correctly identifying those patients who are septic, but who have negative culture results due to problems with blood sampling. Unfortunately, these ancillary tests may have a good negative predictive value (i.e., normal values are reassuring that bloodstream infection is not present) but low positive predictive value. 39 The sensitivity, specificity, and negative and positive predictive values are all dependent on serum levels used to define abnormal and the number of times the test is repeated. [34] [35] [36] 40, 41 High levels of all of these tests can be seen in neonates who do not have a blood-stream infection.
Serial C-reactive protein measurements are more valuable than single measurements, and, in patients who are suspected of having sepsis, may be useful in conjunction with leukocyte counts in making the decision to withhold or stop treatment after negative blood cultures, but they should not be used, in isolation, to decide who should receive a full course of antibiotics. 35, [42] [43] [44] [45] In very-lowbirth-weight infants, fungal and Gram-negative pathogens are associated with a lower platelet count and more prolonged thrombocytopenia compared with Gram-positive pathogens; therefore, changes in platelet counts may be useful as a marker for these more serious infections. 16, 46 PREDISPOSING FACTORS ASSOCIATED WITH NOSOCOMIAL SEPSIS Host-related Premature and very-low-birth-weight infants appear to be particularly vulnerable to nosocomial sepsis due to their relative immune deficiency (e.g., poor phagocytosis, hypogammaglobinemia, etc.). 15 Numerous other factors associated with an increased risk of nosocomial infection include: neutropenia associated with hypertensive mother, 47, 48 degree of prematurity, 1, 7, 15, 49 prolonged rupture of membranes, 50 and maternal disease or infection. 50 Male gender and decreased baseline serum immunoglobulin G concentrations were also associated with an increased risk of blood culture proven sepsis.
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Clinical practice-related Clinical practices can also be associated with an increased risk of acquiring an infection. Empirical or prior antibiotic use 51, 52 and history of treatment with dexamethasone increases the risk by as much as 60%. 53 Analysis of bacteremia/sepsis and meningitis among infants enrolled in a clinical trial evaluating the efficacy of postnatal steroids showed that infants randomly assigned to treatment with dexamethasone (started at 2 weeks after birth at 0.25 mg/kg/dose every 12 hours, then tapered over 2 weeks) were significantly more likely than neonates assigned to placebo to have a positive blood culture result (48 vs 30%, RR 1.62; 95% CI ¼ 1.20 to 2.18) and definite bacteremia/sepsis/meningitis (22 vs 14%, RR 1.60; 95% CI ¼ 1.02 to 2.51). 53 H2 blocker therapy (before study entry) was also associated with a significantly increased risk of definite infection (adjusted OR ¼ 3.19, 95% CI ¼ 1.38 to 7.38). 53 In addition, cesarean-section delivery has been reported to be associated with a significantly decreased risk of nosocomial sepsis (adjusted OR ¼ 0.56, 95% CI ¼ 0.33 to 0.93). 53 Clinical practice factors associated with an increased likelihood that the neonate has nosocomial fungal sepsis include: need for mechanical ventilation, 1, 7, 15, 49 exposure to a central venous catheter, 54, 55 catheter hub manipulation and colonization, [56] [57] [58] prolonged exposure to total parenteral nutrition and/or intravenous lipids, 54, 59 delayed enteral feedings, 54 multiple blood cultures in the preceding 14 days, and exposure to broad-spectrum antibiotics (especially third-generation cephalosporins). [60] [61] [62] [63] [64] [65] [66] [67] [68] In addition, heparin may elicit a superantigen response (toxic shock) from Candida albicans and increase the virulence of Candida. 69 Understanding these risk factors and adjusting clinical practice to reduce the risk may reduce the incidence of nosocomial infection and improve outcomes.
Environmental Factors
In the 1970 s, most NICUs maintained near-operating-room conditions based on the concept that the greatest infection risk comes from the outside. In the 1980 s, recognition that most infection comes from within the NICU led to relaxation of parental visiting limitations. It was also in the 1980 s that cramped conditions were recognized as fostering infection, resulting in an increase in floor space allocation. In the 1990 s, there was increased recognition of parental needs for space and privacy at the bedside and studies have shown that parental contact was not harmful, even when it is skin-to-skin.
Today, justified concerns remain about infection entering the NICU from the community (primarily viral-respiratory syncytial virus, Rotavirus, ''colds and flu'', and varicella) and there are major concerns for cross-contamination (e.g., methicillin-resistant Staph aureus) and colonizing organisms becoming invasive (e.g., Staph epidermidis, Candida), especially among very premature and extremely-low-birth-weight neonates.
Numerous NICU outbreaks of infection have been reported. The vast majority of clustered cases for any pathogen have been found to be genetically similar strains with transmission due to crosscontamination from a small number of health care workers. Clusters of cases with cytomegalovirus and coagulase-negative Staphylococci may also originate from multiple strains. 70 Reservoirs for transmission are numerous: laundry, 71 soap bottles and sinks, 72, 73 hand lotion, 74 pet dog, 75 bed toys, 76 blood gas analyzer, 25, 77 ventilator circuits, 78 multi-use vials, 79 sibling-tomother-to-patient, 80 water tap, 81 hands, 82, 83 suction equipment, 84 air conditioner, 85 wooden tongue depressors, 86 water bath for blood products, 87 expressed mother's milk, 88, 89 powdered milk, 90-92 latex gloves, 93 resuscitator, 94 and saline for heparin dilution. 95 About 85% of all NICU surfaces will grow nosocomial pathogens, with over half contaminated by two or more pathogenic organisms.
96
Central line-related factors Gaynes et al. 10 reported a median of 5.1 blood stream infections per 1000 umbilical-or central-catheter days for the 1500-g-or-more birth-weight group and 14.6 blood stream infections per 1000 umbilical-or central-catheter days for the less-than-1500-g birthweight group. Both hyperalimentation fluids and intralipids can serve as culture media for bacteria and fungus. [97] [98] [99] [100] In a retrospective analysis of the relationship between lipids and sepsis in very low-birth-weight infants, two factors were shown to be independent of gestational age and birth weight in increasing the risk of line infection F intravenous lipid use and any surgically or percutaneous placed central catheter. 99 Infants with coagulasenegative Staphylococci bacteremia are five times as likely as controls to have received intravenous lipid emulsion before the onset of bacteremia and 56% of all cases of nosocomial bacteremia could be associated with lipid administration. 100 As lipids are a critical part of parenteral nutrition in premature infants, they remain an essential part of early management. Clinicians must balance the risk of infection vs the benefit of enhanced caloric intake when deciding how early to curtail the use of intravenous lipids. Malnutrition also increases the risk of opportunistic infections.
CONCLUSIONS
Nosocomial sepsis is a serious problem for neonates who are admitted for intensive care. Since it is associated with increases in mortality, morbidity, and prolonged length of hospital stay, both the human and fiscal costs of these infections are high. Although the rate of nosocomial sepsis increases with the degree of both prematurity and low birth weight, no specific lab test has been shown to be very useful in improving our ability to predict who has a ''real'' blood-stream infection and, therefore, who needs to be treated with a full course of antibiotics. As a result, antibiotic use is double the rate of ''proven'' sepsis and we are facilitating the growth of resistant organisms in the neonatal intensive care unit. The purpose of this article is to review the topic of nosocomial infections in neonates. This paper represents the first in a two-part series. In our next paper, we will review strategies for the prevention and treatment of nosocomial infection.
